博碩士論文 etd-0009114-122645 詳細資訊


[回到前頁查詢結果 | 重新搜尋]

姓名 張珀銀(Po-Yin Chang) 電子郵件信箱 E-mail 資料不公開
畢業系所 資訊管理學系研究所(Information Management)
畢業學位 博士(Ph.D.) 畢業時期 102學年第2學期
論文名稱(中) 台灣地區男性肺癌組織病理型態發生率趨勢分析與空氣污染之相關性研究
論文名稱(英) A study on association between male lung cancer incidence trends analysis by histologic types and air pollution in Taiwan
檔案
  • etd-0009114-122645.pdf
  • 本電子全文僅授權使用者為學術研究之目的,進行個人非營利性質之檢索、閱讀、列印。
    請遵守中華民國著作權法之相關規定,切勿任意重製、散佈、改作、轉貼、播送,以免觸法。
    論文使用權限

    紙本論文:5 年後公開 (2019-01-09 公開)

    電子論文:使用者自訂權限:校內 5 年後、校外 5 年後公開

    論文語文/頁數 中文/77
    統計 本論文已被瀏覽 5391 次,被下載 78 次
    摘要(中) 背景:儘管台灣30年來吸菸率大幅的下降,但台灣男性肺癌仍未有明顯的下降趨勢。本研究進行分析1995-2008年之間台灣男性肺癌病理組織型態之發生率與抽菸率之間的關係。
    方法:本研究之年齡標準化發生率以世界衛生組織所公佈的2000年世界人口為計算基礎,以年齡-期間-世代模型進行分析,進行觀察年齡、期間與世代效果對肺癌趨勢的影響。
    結果: 1970年代台灣男性吸菸率持續下降,經過30年後台灣男性肺癌仍維持高發生率趨勢。而與吸菸弱相關的腺癌發生率已大幅成長,完全取代鱗狀上皮細胞癌成為最常見的男性肺癌病理組織型態。從本研究的分析結果獲知,台灣抽菸率的下降,而男性肺癌高發生率趨勢,未來應加入抽菸之外的環境風險因子進行解釋台灣的男性肺癌趨勢。而空氣污染因子以懸浮粒子(PM₁₀)、二氧化硫(SO₂)、臭氧(O₃)普遍上有正相關性。
    本研究之結果可作為台灣未來的肺癌預防重點,尤其對於肺癌防治現況而言,除了更嚴格的菸害防治政策外,仍極需納入其他的潛在風險因子進行肺癌預防控制,如控制石化工業廢氣、汽機車廢氣排放等產生懸浮粒子(PM₁₀)、二氧化硫(SO₂)、臭氧(O₃)空氣污染源的活動。
    摘要(英) Background: Although radical shifts in smoking trends over the past few decades, male lung cancer remains a major cause of cancer deaths in many developed countries, and one of the most important public health issues. This study analyzed the recent trends in male lung cancer incidence rates with smoking prevalence in Taiwan (1995-2008) by histological subtypes.
    Methods: Age-standardized incidence rates were computed using WHO (2000) standard population as reference, where age, period and cohort effects are analyzed by Poisson APC models to see how they affect the trend.
    Results: Nevertheless smoking prevalence in Taiwan drops since 1976, the male lung cancer incidence rate still increase until 2004, and adenocarcinoma cancer has replaced squamous cell carcinoma as the most common lung cancer subtype. The results suggested that future cancer trends analysis could benefit from the model included potential air pollution factors as PM₁₀, SO₂, and O₃.
    Contribution: Detail analyses show that the increased incidence cases may not fully explained by the previous studies arguing that Taiwan’s future lung cancer prevention focus should include not only tobacco control but also other possible risk factors as air pollution factors: PM₁₀, SO₂, and O₃.
    關鍵字(中)
  • 空氣污染
  • 空氣污染指標
  • 年齡-期間-世代模型
  • 抽菸率
  • 肺癌
  • 關鍵字(英)
  • Smoking Prevalence
  • Age-Period-Cohort Model
  • Lung Cancer
  • Pollutant Standards Index
  • Air Pollution
  • 論文目次 論文審定書 i
    誌 謝 ii
    中文摘要 iii
    英文摘要 iv
    目 錄 vi
    圖 次 viii
    表 次 x
    第一章 緒論 1
    第一節 研究背景與動機 1
    第二節 研究目的 5
    第二章 文獻探討 6
    第一節 肺癌 6
    國內外肺癌流行病學現況 6
    肺癌的類型 6
    小細胞癌(Small Cell Lung Cancer) 7
    非小細胞癌簡介 7
    第二節 年齡-期間-世代模型 15
    第三章 研究方法 18
    第一節 18
    研究類型 18
    研究基本單位 18
    發生率與人口資料 19
    癌症登記檔的資料品質 19
    台灣成人吸菸率 20
    第二節 統計方法 21
    APC模型設定 21
    第四章 研究結果與討論 23
    第一節 年齡-期間-世代模型適配結果 23
    世代效應 25
    期間效應 27
    第二節 空氣污染分析結果 27
    空氣污染分析一:台灣整體空氣污染趨勢 28
    台灣男性高肺癌標準化發生率之縣市 29
    空氣污染縣市與肺癌發生率之關係 31
    研究限制 36
    第五章 結論與建議 37
    參考文獻 39
    附錄 49
    第一節 縣市肺癌發生率發生率與空污趨勢 49
    基隆市 49
    宜蘭縣 50
    台北縣 50
    桃園縣 51
    台中市 51
    台中縣 52
    彰化縣 52
    雲林縣 53
    嘉義縣 53
    台南市 54
    台南縣 54
    第二節 年齡標準化發生率計算 55
    第三節 APC模型分析 61
    第四節 相關分析 64
    參考文獻 [1] 台灣行政院衛生署. 100年國人主要死因統計. 2012 2012/05/25 [cited 2012 2012/12/28]; Available from: http://www.doh.gov.tw/CHT2006/DM/DM2_p01.aspx?class_no=25&level_no=1&doc_no=84788.
    [2] Malarcher, A.M., et al., Methodological issues in estimating smoking-attributable mortality in the United States. American Journal of Epidemiology, 2000. 152(6): p. 573.
    [3] Liu, Z., Smoking and lung cancer in China: combined analysis of eight case-control studies. International journal of epidemiology, 1992. 21(2): p. 197.
    [4] Yang, G., et al., Smoking in China. JAMA: the journal of the American Medical Association, 1999. 282(13): p. 1247.
    [5] WANG, J.-D., Occupational Cancer Diagnosis Standards and Evidence-based Study(I) IOSH9- M303, 2008.
    [6] Koskela, R.S., et al., Silica dust exposure and lung cancer. Scandinavian journal of work, environment & health, 1994. 20(6): p. 407-416.
    [7] Gustavsson, P., et al., Occupational exposure and lung cancer risk: a population-based case-referent study in Sweden. American Journal of Epidemiology, 2000. 152(1): p. 32.
    [8] Kazerouni, N., et al., Sex differences in COPD and lung cancer mortality trends-United States, 1968-1999. Journal of Women's Health, 2004. 13(1): p. 17-23.
    [9] Pierce, J.P., et al., Forty years of faster decline in cigarette smoking in California explains current lower lung cancer rates. Cancer Epidemiology Biomarkers & Prevention, 2010. 19(11): p. 2801-2810.
    [10] Steven Dunstan, S.R., General Lifestyle Survey Overview in Office for National Statistics, S. Dunstan, Editor. 2012, London.
    [11] Nawa, T., et al., A decrease in lung cancer mortality following the introduction of low-dose chest CT screening in Hitachi, Japan. Lung Cancer, 2012.
    [12] 香港政府統計處. 非傳染病及風險因素. 2012; Available from: http://www.chp.gov.hk/tc/content/9/25/49.html.
    [13] Bast, R.C., et al., Holland-frei cancer medicine. 2000.
    [14] Hong, W.K. Tumors of the Lungs. 2008; Available from: http://www.merckmanuals.com/professional/pulmonary_disorders/tumors_of_the_lungs/lung_carcinoma.html.
    [15] Thun, M.J., et al., Lung cancer occurrence in never-smokers: an analysis of 13 cohorts and 22 cancer registry studies. PLoS medicine, 2008. 5(9): p. e185.
    [16] Gorlova, O.Y., et al., Aggregation of cancer among relatives of never‐smoking lung cancer patients. International journal of cancer, 2007. 121(1): p. 111-118.
    [17] Hackshaw, A.K., M.R. Law, and N.J. Wald, The accumulated evidence on lung cancer and environmental tobacco smoke. Bmj, 1997. 315(7114): p. 980-988.
    [18] Catelinois, O., et al., Lung cancer attributable to indoor radon exposure in france: impact of the risk models and uncertainty analysis. Environmental health perspectives, 2006. 114(9): p. 1361.
    [19] Heiss, C., et al., Brief secondhand smoke exposure depresses endothelial progenitor cells activity and endothelial function: sustained vascular injury and blunted nitric oxide production. Journal of the American College of Cardiology, 2008. 51(18): p. 1760-1771.
    [20] Collins, L.G., et al., Lung cancer: diagnosis and management. American family physician, 2007. 75(1): p. 56.
    [21] Barbone, F., et al., Cigarette smoking and histologic type of lung cancer in men. CHEST Journal, 1997. 112(6): p. 1474-1479.
    [22] Travis, W.D., Pathology of lung cancer. Clinics in Chest Medicine, 2011. 32(4): p. 669.
    [23] Subramanian, J. and R. Govindan, Lung cancer in never smokers: a review. Journal of Clinical Oncology, 2007. 25(5): p. 561-570.
    [24] Raz, D.J., et al., Bronchioloalveolar carcinoma: a review. Clinical lung cancer, 2006. 7(5): p. 313-322.
    [25] Seo, J.B., et al., Atypical Pulmonary Metastases: Spectrum of Radiologic Findings1. Radiographics, 2001. 21(2): p. 403-417.
    [26] Dishop, M.K. and S. Kuruvilla, Primary and metastatic lung tumors in the pediatric population: a review and 25-year experience at a large children's hospital. 2009.
    [27] Samet, J.M., et al., Cigarette smoking and lung cancer in New Mexico. American Journal of Respiratory and Critical Care Medicine, 1988. 137(5): p. 1110-1113.
    [28] Villeneuve, P. and Y. Mao, Lifetime probability of developing lung cancer, by smoking status, Canada. Canadian journal of public health. Revue canadienne de santé publique, 1994. 85(6): p. 385.
    [29] Hecht, S.S., Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nature Reviews Cancer, 2003. 3(10): p. 733-744.
    [30] Sopori, M., Effects of cigarette smoke on the immune system. Nature Reviews Immunology, 2002. 2(5): p. 372-376.
    [31] Novello, A.C., Surgeon General's report on the health benefits of smoking cessation. Public Health Reports, 1990. 105(6): p. 545.
    [32] Nordquist, L.T., et al., Improved survival in never-smokers vs current smokers with primary adenocarcinoma of the lung. CHEST Journal, 2004. 126(2): p. 347-351.
    [33] Environmental Tobacco Smoke:Measuring Exposures and Assessing Health Effects. 1986: The National Academies Press.
    [34] Boffetta, P., et al., Multicenter case-control study of exposure to environmental tobacco smoke and lung cancer in Europe. Journal of the National Cancer Institute, 1998. 90(19): p. 1440-1450.
    [35] Poswillo, D., Report of the scientific committee on tobacco and health. London: The Stationery Office, 1998.
    [36] Council, N.H.a.M.R. The health effects and regulation of passive smoking. 1994.
    [37] Schick, S. and S. Glantz, Philip Morris toxicological experiments with fresh sidestream smoke: more toxic than mainstream smoke. Tobacco control, 2005. 14(6): p. 396-404.
    [38] Thun, M.J., et al., Lung cancer death rates in lifelong nonsmokers. Journal of the National Cancer Institute, 2006. 98(10): p. 691-699.
    [39] Sun, S., J.H. Schiller, and A.F. Gazdar, Lung cancer in never smokers—a different disease. Nature Reviews Cancer, 2007. 7(10): p. 778-790.
    [40] Elders, M.J., et al., The report of the Surgeon General: preventing tobacco use among young people. American journal of public health, 1994. 84(4): p. 543-547.
    [41] U.S. Department of Health and Human Services, H., Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, The Health Consequences of Smoking: A Report of the Surgeon General. 2004, U.S. Department of Health and Human Services: Atlanta, GA.
    [42] IARC. Evaluating the Effectiveness of Smoke-free Policies. 2009; Available from: http://apps.who.int/bookorders/anglais/detart1.jsp?codlan=1&codcol=76&codcch=29.
    [43] Environmental-Protection-Agency, U.S. Radon. 2012 [cited 2013 2013/01/15]; Available from: http://www.epa.gov/rpdweb00/radionuclides/radon.html.
    [44] Field, R.W., et al., Residential Radon Gas Exposure and Lung Cancer The Iowa Radon Lung Cancer Study. American Journal of Epidemiology, 2000. 151(11): p. 1091-1102.
    [45] O'Reilly, K.M., et al., Asbestos-related lung disease. American family physician, 2007. 75(5): p. 683-688.
    [46] Darnton, A.J., D.M. McELVENNY, and J.T. Hodgson, Estimating the number of asbestos-related lung cancer deaths in Great Britain from 1980 to 2000. Annals of Occupational Hygiene, 2006. 50(1): p. 29-38.
    [47] Leroux, C., et al., Jaagsiekte Sheep Retrovirus (JSRV): from virus to lung cancer in sheep. Veterinary research, 2007. 38(2): p. 211-228.
    [48] Palmarini, M. and H. Fan, Retrovirus-induced ovine pulmonary adenocarcinoma, an animal model for lung cancer. Journal of the National Cancer Institute, 2001. 93(21): p. 1603-1614.
    [49] Cheng, Y.W., et al., The association of human papillomavirus 16/18 infection with lung cancer among nonsmoking Taiwanese women. Cancer research, 2001. 61(7): p. 2799-2803.
    [50] Zheng, H., et al., Oncogenic role of JC virus in lung cancer. The Journal of pathology, 2007. 212(3): p. 306-315.
    [51] Pope III, C.A., et al., Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution. JAMA: the journal of the American Medical Association, 2002. 287(9): p. 1132-1141.
    [52] Krewski, D., et al., Mortality and long-term exposure to ambient air pollution: ongoing analyses based on the American Cancer Society cohort. Journal of Toxicology and Environmental Health, Part A, 2005. 68(13-14): p. 1093-1109.
    [53] Valavanidis, A., K. Fiotakis, and T. Vlachogianni, Airborne particulate matter and human health: toxicological assessment and importance of size and composition of particles for oxidative damage and carcinogenic mechanisms. Journal of Environmental Science and Health, Part C, 2008. 26(4): p. 339-362.
    [54] Britain, G., The Registrar General's decennial supplement: England and Wales, 1961. Occupational mortality tables. 1971: HM Stationery Office.
    [55] Cole, P., R. Hoover, and G.H. Friedell, Occupation and cancer of the lower urinary tract. Cancer, 1972. 29(5): p. 1250-1260.
    [56] Coggon, D., B. Pannett, and E.D. Acheson, Use of job-exposure matrix in an occupational analysis of lung and bladder cancers on the basis of death certificates. Journal of the National Cancer Institute, 1984. 72(1): p. 61-65.
    [57] Schoenberg, J.B., et al., Case-control study of bladder cancer in New Jersey. I. Occupational exposures in white males. Journal of the National Cancer Institute, 1984. 72(5): p. 973-981.
    [58] Coggon, D., et al., A survey of cancer and occupation in young and middle aged men. I. Cancers of the respiratory tract. British journal of industrial medicine, 1986. 43(5): p. 332-338.
    [59] Law, C., K. Shanmugaratnam, and N. Day, Incidence rates of specific histological types of lung cancer in Singapore Chinese dialect groups, and their aetiological significance. International journal of cancer, 1976. 17(3): p. 304-309.
    [60] Ger, L., et al., Risk factors of lung cancer]. Journal of the Formosan Medical Association= Taiwan yi zhi, 1992. 91: p. S222.
    [61] MacLennan, R., et al., Risk factors for lung cancer in Singapore Chinese, a population with high female incidence rates. International journal of cancer, 1977. 20(6): p. 854-860.
    [62] Ko, Y.-C., et al., Risk factors for primary lung cancer among non-smoking women in Taiwan. International journal of epidemiology, 1997. 26(1): p. 24-31.
    [63] Liu, Z., X. He, and R.S. Chapman, Smoking and other risk factors for lung cancer in Xuanwei, China. International journal of epidemiology, 1991. 20(1): p. 26-31.
    [64] Ko, Y.-C., et al., Chinese food cooking and lung cancer in women nonsmokers. American Journal of Epidemiology, 2000. 151(2): p. 140-147.
    [65] Gao, Y.T., et al., Lung cancer among Chinese women. International journal of cancer, 1987. 40(5): p. 604-609.
    [66] Larsen, J.E. and J.D. Minna, Molecular biology of lung cancer: clinical implications. Clinics in Chest Medicine, 2011. 32(4): p. 703.
    [67] Salgia, R. and A.T. Skarin, Molecular abnormalities in lung cancer. Journal of Clinical Oncology, 1998. 16(3): p. 1207-1217.
    [68] Herbst, R.S., J.V. Heymach, and S.M. Lippman, Lung Cancer. New England Journal of Medicine, 2008. 359(13): p. 1367-1380.
    [69] Aviel-Ronen, S., et al., K-ras mutations in non-small-cell lung carcinoma: a review. Clinical lung cancer, 2006. 8(1): p. 30-38.
    [70] Devereux, T.R., J.A. Taylor, and J.C. Barrett, Molecular Mechanisms of Lung Cancer Interaction of Environmental and Genetic Factors. CHEST Journal, 1996. 109(3_Supplement): p. 14S-19S.
    [71] Engels, E.A., et al., Systematic evaluation of genetic variants in the inflammation pathway and risk of lung cancer. Cancer research, 2007. 67(13): p. 6520-6527.
    [72] Wenzlaff, A., et al., CYP1A1 and CYP1B1 polymorphisms and risk of lung cancer among never smokers: a population-based study. Carcinogenesis, 2005. 26(12): p. 2207-2212.
    [73] Son, J.W., et al., Polymorphisms in the< i> caspase-8</i> gene and the risk of lung cancer. Cancer genetics and cytogenetics, 2006. 169(2): p. 121-127.
    [74] Yin, J., et al., The DNA repair gene< i> XRCC1</i> and genetic susceptibility of lung cancer in a northeastern Chinese population. Lung Cancer, 2007. 56(2): p. 153-160.
    [75] Tomoda, K., et al., Preparation and properties of inhalable nanocomposite particles for treatment of lung cancer. Colloids and Surfaces B: Biointerfaces, 2009. 71(2): p. 177-182.
    [76] Lan, Q., et al., Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia. Nature Genetics, 2012. 44(12): p. 1330-1335.
    [77] Longo, D.L., et al., Harrison's™ PRINCIPLES OF INTERNAL MEDICINE. 2012: McGraw-Hill.
    [78] Fan, Y.G., et al., Association between sputum atypia and lung cancer risk in an occupational cohort in Yunnan, China. CHEST Journal, 2009. 135(3): p. 778-785.
    [79] Burdett, S., et al., Chemotherapy in addition to supportive care improves survival in advanced non-small-cell lung cancer: A systematic review and meta-analysis of individual patient data from 16 randomized controlled trials-NSCLC meta-analyses collaborative group. 2008.
    [80] Fishman, A.P., et al., Fishman's pulmonary diseases and disorders. 4th. 2008: McGraw-Hill Inc.
    [81] Clegg, A., et al., Clinical and cost effectiveness of paclitaxel, docetaxel, gemcitabine, and vinorelbine in non-small cell lung cancer: a systematic review. Thorax, 2002. 57(1): p. 20-28.
    [82] Fuld, A.D., K.H. Dragnev, and J.R. Rigas, Pemetrexed in advanced non-small-cell lung cancer. Expert Opinion on Pharmacotherapy, 2010. 11(8): p. 1387-1402.
    [83] National-Cancer-Institute. SEER stat fact sheets: Lung and Bronchus. 2012 [cited 2012 2012/01/17]; Available from: http://seer.cancer.gov/statfacts/html/lungb.html.
    [84] WHO Department of Gender, W.a.H., Gender in lung cancer and smoking research. 2004.
    [85] Zhang, J., J.I.A.X. Ou, and C.X.U.E. Bai, Tobacco smoking in China: prevalence, disease burden, challenges and future strategies. Respirology, 2011. 16(8): p. 1165-1172.
    [86] Behera, D. and T. Balamugesh, Lung cancer in India. The Indian journal of chest diseases & allied sciences, 2004. 46(4): p. 269.
    [87] IARC, I. Smoke, and I. Smoking, IARC monographs on the evaluation of carcinogenic risks to humans.
    [88] Lum, K.L., et al., Signed, sealed and delivered:“big tobacco” in Hollywood, 1927–1951. Tobacco control, 2008. 17(5): p. 313-323.
    [89] Carstensen, B., Age–period–cohort models for the Lexis diagram. Statistics in medicine, 2007. 26(15): p. 3018-3045.
    [90] Holford, T.R., The estimation of age, period and cohort effects for vital rates. Biometrics, 1983: p. 311-324.
    [91] Holford, T.R., Understanding the effects of age, period, and cohort on incidence and mortality rates. Annual Review of Public Health, 1991. 12(1): p. 425-457.
    [92] Holford, T.R., Age–period–cohort analysis. Encyclopedia of biostatistics, 2005.
    [93] Clayton, D. and E. Schifflers, Models for temporal variation in cancer rates. II: age–period–cohort models. Statistics in medicine, 1987. 6(4): p. 469-481.
    [94] Clayton, D. and E. Schifflers, Models for temporal variation in cancer rates. I: age–period and age–cohort models. Statistics in medicine, 1987. 6(4): p. 449-467.
    [95] Robertson, C. and P. Boyle, Age–period–cohort analysis of chronic disease rates. I: Modelling approach. Statistics in medicine, 1998. 17(12): p. 1305-1323.
    [96] Robertson, C. and P. Boyle, Age–period–cohort models of chronic disease rates. II: graphical approaches. Statistics in medicine, 1998. 17(12): p. 1325-1340.
    [97] Tarone, R.E. and K.C. Chu, Evaluation of birth cohort patterns in population disease rates. American Journal of Epidemiology, 1996. 143(1): p. 85-91.
    [98] Nelder, J.A. and R.W.M. Wedderburn, Generalized linear models. Journal of the Royal Statistical Society. Series A (General), 1972: p. 370-384.
    [99] Osmond, C. and M.J. Gardner, Age, period and cohort models applied to cancer mortality rates. Statistics in medicine, 2006. 1(3): p. 245-259.
    [100] Clayton, D. and E. Schifflers, Models for temporal variation in cancer rates. I: age–period and age–cohort models. Statistics in medicine, 2006. 6(4): p. 449-467.
    [101] Robertson, C., S. Gandini, and P. Boyle, Age-period-cohort models: a comparative study of available methodologies. Journal of clinical epidemiology, 1999. 52(6): p. 569-583.
    [102] Tarone, R.E. and K.C. Chu, Implications of birth cohort patterns in interpreting trends in breast cancer rates. Journal of the National Cancer Institute, 1992. 84(18): p. 1402-1410.
    [103] Carstensen, B., Demography and epidemiology: Age-Period-Cohort models in the computer age. 2005.
    [104] Shen, Y.C., et al., Significant difference in the trends of female breast cancer incidence between Taiwanese and Caucasian Americans: implications from age-period-cohort analysis. Cancer Epidemiology Biomarkers & Prevention, 2005. 14(8): p. 1986-1990.
    [105] LEE, W.E.N.C. and R.S. LIN, Age-period-cohort analysis of pancreatic cancer mortality in Taiwan, 1971–1986. International journal of epidemiology, 1990. 19(4): p. 839-847.
    [106] Ahmad, O.B., et al., Age standardization of rates: a new WHO standard. 2001: World Health Organization Geneva.
    [107] Taiwan Cancer Registry, D.o.H., R.O.C (Taiwan), Cancer Incidence and Mortality Rates in Taiwan. 2008, Taiwan Cancer Registry, Department of Health, R.O.C (Taiwan).
    [108] Brambilla, E., et al., The new World Health Organization classification of lung tumours. European respiratory journal, 2001. 18(6): p. 1059.
    [109] 尤瑞鴻, 台灣地區癌症登記之品質評估. 1992, National Taiwan University Department of Public Health.
    [110] Lu, T.H., et al., Factors associated with errors in death certificate completion: a national study in Taiwan. Journal of clinical epidemiology, 2001. 54(3): p. 232-238.
    [111] 周碧瑟, 影響臺灣婦女接受子宮頸抹片檢查之因素. 生命科學簡訊, 2000.
    [112] Liaw, Y.P., et al., Cell type specificity of lung cancer associated with nitric oxide. Science of the Total Environment, 2010. 408(21): p. 4931-4934.
    [113] Liaw, Y.P., et al., Cell type specificity of lung cancer associated with air pollution. Science of the Total Environment, 2008. 395(1): p. 23-27.
    [114] Chiang, T.A., et al., Important prognostic factors for the long-term survival of lung cancer subjects in Taiwan. BMC cancer, 2008. 8(1): p. 324.
    [115] 台灣行政院衛生署國民健康局, 台灣菸害防制年報. 2011. p. 67.
    [116] 李蘭 and 潘怜燕, 台灣地區成年人之吸菸率與吸菸行為: 八十八年度之全國性調查. 中華公共衛生雜誌, 1999. 19(6): p. 423-436.
    [117] Carstensen, B. Epi: A package for statistical analysis in epidemiology. 2014; Available from: http://cran.r-project.org/web/packages/Epi/index.html.
    [118] Chongsuvivatwong, V. Functions making R easy for epidemiological calculation. 2014; Available from: http://cran.r-project.org/web/packages/epicalc/index.html.
    [119] Boyle, P. and D. Parkin, Cancer registration: principles and methods. Statistical methods for registries. IARC scientific publications, 1991(95): p. 126.
    [120] Stellman, S.D., et al., Risk of squamous cell carcinoma and adenocarcinoma of the lung in relation to lifetime filter cigarette smoking. Cancer, 1997. 80(3): p. 382-388.
    [121] Alberg, A.J., M.V. Brock, and J.M. Samet, Epidemiology of lung cancer: looking to the future. Journal of Clinical Oncology, 2005. 23(14): p. 3175.
    [122] Khuder, S.A. and A.B. Mutgi, Effect of Smoking Cessation on Major Histologic Types of Lung Cancer*. Chest, 2001. 120(5): p. 1577-1583.
    [123] Lubin, J.H. and N.E. Caporaso, Cigarette smoking and lung cancer: modeling total exposure and intensity. Cancer Epidemiology Biomarkers & Prevention, 2006. 15(3): p. 517-523.
    [124] Wynder, E.L. and J.E. Muscat, The changing epidemiology of smoking and lung cancer histology. Environmental health perspectives, 1995. 103(Suppl 8): p. 143.
    [125] Zheng, T., et al., Time trend and the age‐period‐cohort effect on the incidence of histologic types of lung cancer in connecticut, 1960‐1989. Cancer, 1994. 74(5): p. 1556-1567.
    [126] Joshua, A., et al., Smoking reduction does work: resulting alterations in the incidence and histological subtypes of lung cancer in New South Wales in the last 20 years. Respirology, 2005. 10(2): p. 233-238.
    [127] Blizzard, L. and T. Dwyer, Lung cancer incidence in Australia: Impact of filter‐tip cigarettes with unchanged tar yields. International journal of cancer, 2002. 97(5): p. 679-684.
    [128] Brooks, D.R., et al., Influence of type of cigarette on peripheral versus central lung cancer. Cancer Epidemiology Biomarkers & Prevention, 2005. 14(3): p. 576-581.
    [129] Chen, F., P. Cole, and W.F. Bina, Time trend and geographic patterns of lung adenocarcinoma in the United States, 1973-2002. Cancer Epidemiology Biomarkers & Prevention, 2007. 16(12): p. 2724-2729.
    [130] Wynder, E.L. and G.C. Kabat, The effect of low‐yield cigarette smoking on lung cancer risk. Cancer, 1988. 62(6): p. 1223-1230.
    [131] Thun, M.J., et al., Cigarette smoking and changes in the histopathology of lung cancer. Journal of the National Cancer Institute, 1997. 89(21): p. 1580-1586.
    [132] Raaschou-Nielsen, O., et al., Air pollution from traffic and risk for lung cancer in three Danish cohorts. Cancer Epidemiology Biomarkers & Prevention, 2010. 19(5): p. 1284.
    [133] Yang, C.-Y., et al., Female lung cancer and petrochemical air pollution in Taiwan. Archives of Environmental Health: An International Journal, 1999. 54(3): p. 180-185.
    [134] Liaw, Y.-P., et al., Cell type specificity of lung cancer associated with nitric oxide. Science of The Total Environment, 2010. 408(21): p. 4931-4934.
    [135] 台灣行政院環境保護署. Air Quality Annual Report of R.O.C.(Taiwan). 2011.
    [136] 新竹教育大學. 台灣各縣市分佈圖. 2014; Available from: http://www.aerc.nhcue.edu.tw/8-0/twart-jp/images/taiwan.htm.
    [137] Boffetta, P. and D. Trichopoulos, Cancer of the lung, larynx, and pleura. Textbook of cancer epidemiology, 2002. 2: p. 349-67.
    [138] 台灣行政院環境保護署. 細懸浮微粒管制. 102; Available from: http://air.epa.gov.tw/Public/suspended_particles.aspx.
    口試委員
  • 葉淑娟 - 召集委員
  • 李英俊 - 委員
  • 楊俊毓 - 委員
  • 葉淑惠 - 委員
  • 鄭炳強 - 指導教授
  • 口試日期 2014-03-18 繳交日期 2014-01-09

    [回到前頁查詢結果 | 重新搜尋]


    如有任何問題請與論文審查小組聯繫